Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Science Translational Medicine|June 17, 2026
Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantationThomas Wekerle, Moritz Muckenhuber, Andreas Heinzel, et al.
Kidney International Reports|July 9, 2025
Identification and Cross-Platform Validation of Sparse Molecular Classifiers for Antibody-Mediated and T-Cell-Mediated Rejection After Kidney TransplantationJasper Callemeyn, Josué Manik Nava-Sedeño, Dany Anglicheau, et al.
Transplantation|January 9, 2025
Defining an NK Cell-enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER StudyKatelynn S Madill-Thomsen, Patrick T Gauthier, Marwan Abouljoud, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 22, 2026
A Two-Threshold dd-cfDNA Algorithm Improves Detection of Molecular Rejection in Heart TransplantationDr Philip F Halloran, Katelynn S Madill-Thomsen, D Giovanni Biagini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2024
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trialAylin Akifova, Klemens Budde, Kerstin Amann, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to TreatmentCarmen Lefaucheur, Denis Viglietti, Luis G Hidalgo, et al.
The Lancet Regional Health. Europe|July 19, 2026
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extensionKatharina A Mayer, Matthias Diebold, Eva V Schrezenmeier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2020
The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER studyKatelynn Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 15, 2021
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER studyKatelynn S Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, et al.
The New England Journal of Medicine|May 28, 2024
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A Mayer, Eva Schrezenmeier, Matthias Diebold, et al.
Pageof 18